B3GNT6 and colorectal cancer: Results indicated that in the GI tract, the stomach, esophagus, and normal colorectal tissues, B3GNT6 mRNA levels were higher than those in colorectal cancer tissues; however, the small intestine showed low B3GNT6 expression.